Yann Mazabraud sold $3.9M of Rhythm Pharmaceuticals (RYTM)

Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.

Value, as filed

$3.9M

75,000 sh across 2 lots

Executed

Mar 14 2025

the trade date, as filed

Disclosed

Mar 18 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

YM Yann Mazabraud EVP, Head of International profile →

Yann Mazabraud (EVP, Head of International) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $6.6M of RYTM (57,000 sh across 6 lots, as filed), executed Aug 12.

The name

RYTM Rhythm Pharmaceuticals, Inc. RYTM · Healthcare · 47 filings in 24 months ticker →

Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Yann Mazabraud in RYTM

RYTMSALE Rhythm Pharmaceuticals, Inc. $6.6M
57,000 sh across 6 lots
Exec Aug 12
Filed Aug 14 · 7:01 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $439K
6,745 sh × $65.08
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. $1.1M
17,750 sh across 2 lots
Exec Apr 8 2025
Filed Apr 10 2025 · 5:30 PM ET